Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease
Loading...
Date
2022
Authors
Beaton, Andrea
Okello, Emmy
Rwebembera, Joselyn
Alepere, Juliet
Lwabi, Peter
Nakitto, Miriam
Ndagire, Emma
Omara, Isaac O.
Karthikeyan, Ganesan
Steer, Andrew C.
Journal Title
Journal ISSN
Volume Title
Publisher
New England Journal of Medicine
Abstract
Rheumatic heart disease affects more than 40.5 million people worldwide and results in 306,000 deaths annually. Echocardiographic screening detects rheumatic heart disease at an early, latent stage. Whether secondary antibiotic prophylaxis is effective in preventing progression of latent rheumatic heart disease is unknown.
Description
Keywords
Latent Rheumatic Heart Disease, Antibiotic Prophylaxis
Citation
Beaton, A., Okello, E., Rwebembera, J., Grobler, A., Engelman, D., Alepere, J., ... & Steer, A. C. (2022). Secondary antibiotic prophylaxis for latent rheumatic heart disease. New England Journal of Medicine, 386(3), 230-240.DOI: 10.1056/NEJMoa2102074